Why the study?
Do common risk stratification indices (ASA, CCI, and mFI) accurately predict postoperative adverse events in stage IV cancer patients undergoing surgery for bowel obstruction?
Do common risk stratification indices (ASA, CCI, and mFI) accurately predict postoperative adverse events in stage IV cancer patients undergoing surgery for bowel obstruction?
Common risk stratification indices (ASA, CCI, mFI) are insufficient for predicting postoperative adverse events in stage IV cancer patients undergoing surgery for bowel obstruction, highlighting the need for tailored preoperative risk tools.
Answers are grounded in this paper and cite their sources.
These indices should not yet guide risk discussions in disseminated malignancy; leaves open development of tailored predictors.
ASA, CCI, and mFI are limited in their ability to predict postoperative adverse events among DMa patients undergoing surgery for bowel obstruction. These data suggest that a more tailored preoperative risk stratification tool would improve treatment planning.
No takes yet. Share an insight, caveat, or question.
Bateni et al. (2017) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: